Market Cap 283.45M
Revenue (ttm) 0.00
Net Income (ttm) -44.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 384,200
Avg Vol 787,408
Day's Range N/A - N/A
Shares Out 51.63M
Stochastic %K 68%
Beta 1.38
Analysts Strong Sell
Price Target $25.00

Company Profile

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving pare...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 844 0337
Address:
345 Park Avenue South, 3rd Floor, New York, United States
RhoInterestR
RhoInterestR Dec. 27 at 9:58 AM
$TARA Markets appear to be rewarding companies that show durable execution rather than rapid narrative shifts. Cash discipline will likely dictate investor patience. Durability across environments would extend investor horizons. Momentum becomes sustainable only when delivery keeps pace.
0 · Reply
Eddie5150
Eddie5150 Dec. 18 at 5:24 PM
$TARA why all the selling now?
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 11:05 PM
$TARA Share Price: $5.34 Contract Selected: May 15, 2026 $5 Calls Buy Zone: $0.85 – $1.05 Target Zone: $1.35 – $1.66 Potential Upside: 51% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
lacyauto
lacyauto Dec. 15 at 9:41 PM
$TARA 20+ by March if good news comes feb
0 · Reply
LordGrundlefunk
LordGrundlefunk Dec. 12 at 6:31 PM
$TARA I'm pretty new to investing, why is the stock jumping in value, then dropping so sharply?
0 · Reply
backtroid
backtroid Dec. 11 at 7:28 PM
$TARA 10% up? we need 1000% up
0 · Reply
pablo4
pablo4 Dec. 11 at 5:46 PM
$TARA this is going way out on a limb but I believe TARA has every chance to be a 20 to 50 dollar a share stock in the next year if the bio market holds and phase 3 unresponsive NMIBC goes as expected. JMO
1 · Reply
JohnTrack
JohnTrack Dec. 8 at 9:28 PM
$TARA fast headline, go peek... https://www.rapidticker.com/news/tara-sec-filing-6d00e2
0 · Reply
pablo4
pablo4 Dec. 8 at 9:21 PM
$TARA deal closed!
2 · Reply
mimiwor
mimiwor Dec. 8 at 3:40 PM
$TARA not selling here just swing... They have data read in few months.
0 · Reply
Latest News on TARA
Protara Announces Closing of $75 Million Public Offering

Dec 8, 2025, 4:05 PM EST - 19 days ago

Protara Announces Closing of $75 Million Public Offering


Protara Announces Pricing of $75 Million Public Offering

Dec 4, 2025, 10:03 PM EST - 22 days ago

Protara Announces Pricing of $75 Million Public Offering


Protara Announces Proposed Public Offering

Dec 4, 2025, 4:15 PM EST - 23 days ago

Protara Announces Proposed Public Offering


Protara Therapeutics: End Of 2025 Proving Eventful Indeed

Dec 4, 2025, 7:30 AM EST - 23 days ago

Protara Therapeutics: End Of 2025 Proving Eventful Indeed


Protara Therapeutics: Rising From The Ashes

Dec 14, 2024, 8:30 AM EST - 1 year ago

Protara Therapeutics: Rising From The Ashes


Protara Announces Closing of $100 Million Public Offering

Dec 11, 2024, 4:05 PM EST - 1 year ago

Protara Announces Closing of $100 Million Public Offering


Protara Therapeutics: Carving New Roads In Bladder Cancer

Dec 10, 2024, 5:00 PM EST - 1 year ago

Protara Therapeutics: Carving New Roads In Bladder Cancer


Protara Announces Pricing of $100 Million Public Offering

Dec 9, 2024, 11:35 PM EST - 1 year ago

Protara Announces Pricing of $100 Million Public Offering


Protara: A Bombed Out Biotech With A Very Positive Skew

Feb 22, 2024, 8:55 AM EST - 2 years ago

Protara: A Bombed Out Biotech With A Very Positive Skew

CGON


RhoInterestR
RhoInterestR Dec. 27 at 9:58 AM
$TARA Markets appear to be rewarding companies that show durable execution rather than rapid narrative shifts. Cash discipline will likely dictate investor patience. Durability across environments would extend investor horizons. Momentum becomes sustainable only when delivery keeps pace.
0 · Reply
Eddie5150
Eddie5150 Dec. 18 at 5:24 PM
$TARA why all the selling now?
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 11:05 PM
$TARA Share Price: $5.34 Contract Selected: May 15, 2026 $5 Calls Buy Zone: $0.85 – $1.05 Target Zone: $1.35 – $1.66 Potential Upside: 51% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
lacyauto
lacyauto Dec. 15 at 9:41 PM
$TARA 20+ by March if good news comes feb
0 · Reply
LordGrundlefunk
LordGrundlefunk Dec. 12 at 6:31 PM
$TARA I'm pretty new to investing, why is the stock jumping in value, then dropping so sharply?
0 · Reply
backtroid
backtroid Dec. 11 at 7:28 PM
$TARA 10% up? we need 1000% up
0 · Reply
pablo4
pablo4 Dec. 11 at 5:46 PM
$TARA this is going way out on a limb but I believe TARA has every chance to be a 20 to 50 dollar a share stock in the next year if the bio market holds and phase 3 unresponsive NMIBC goes as expected. JMO
1 · Reply
JohnTrack
JohnTrack Dec. 8 at 9:28 PM
$TARA fast headline, go peek... https://www.rapidticker.com/news/tara-sec-filing-6d00e2
0 · Reply
pablo4
pablo4 Dec. 8 at 9:21 PM
$TARA deal closed!
2 · Reply
mimiwor
mimiwor Dec. 8 at 3:40 PM
$TARA not selling here just swing... They have data read in few months.
0 · Reply
baralos
baralos Dec. 8 at 2:33 PM
$TARA close the gap and lets go up!! simple and TY Tara
0 · Reply
TwongStocks
TwongStocks Dec. 5 at 10:48 PM
$TARA Prospectus for the offering was filed https://www.sec.gov/Archives/edgar/data/1359931/000121390025118744/ea0268632-424b5_protara.htm • Same terms as this morning. 13,043,479 shares at $5.75. If underwriters exercise their options in full, it rises to 15m shares at $5.75. • 51,630,739 shares outstanding after the offering. Rises to 53,587,260 shares if the underwriters’ option is exercised in full. • Net proceeds expected to be $69.7M and $80.2M if underwriters exercise their options in full. • Shares are allocated to the underwriters as follows: JPM 5,217,391 shares, TS Securities 3,260,870 shares, Piper Sandler 2,608,696 shares, LifeSci Capital 1,304,348 shares, and HCW 652,174 shares.
0 · Reply
LeoS_Crmxt27
LeoS_Crmxt27 Dec. 5 at 8:43 PM
$TARA classic micro biotech volatility, only respect it when volume confirms
0 · Reply
mimiwor
mimiwor Dec. 5 at 8:30 PM
$TARA feeling like squeezing move after market is coming..
0 · Reply
keokeostwiz
keokeostwiz Dec. 5 at 7:11 PM
$TARA Thanks for the gifted shares 5.07-5.18 this am.....do not normally shop this early for XMAS but could not ignore the giveaway.....happy to oblige....hope your 5.07-5.18 brings joy for the holidays
0 · Reply
longterminvs
longterminvs Dec. 5 at 6:26 PM
$TARA The Bio5C Discord lit up this morning with frustrated TARA owners surprised at this raise when the previous was $6.25 a year ago and this was $5.75 with more progress and two recent positive announcements. Many feeling it's very odd with a major catalyst. JNap had this opinion:
1 · Reply
keokeostwiz
keokeostwiz Dec. 5 at 5:51 PM
$TARA The institutions accumulate profits on the mistakes of retail investors.....always doing the opposite....retail selling panic today the signal to buy all one can on this opportunity.....the news could not have been any better......relax and buy
0 · Reply
notreload_ai
notreload_ai Dec. 5 at 4:31 PM
$TARA raised $75 million via a stock sale to fund clinical trials, mainly for TARA-002, a treatment for bladder cancer and rare lymphatic issues. The company's stock dropped 20% following the discounted pricing announcement. https://ir.protaratx.com/news-releases/news-release-details/protara-announces-pricing-75-million-public-offering
0 · Reply
pablo4
pablo4 Dec. 5 at 4:18 PM
$TARA even if it dips a bit again before right back forward, TARA is a great buy now, IMO.
0 · Reply
pablo4
pablo4 Dec. 5 at 3:33 PM
$TARA I think a small minority of retail investors in the market today actually research fundamentals of the companies they own. I believe they chase "stories" and learn to follow charts. Charts can be very helpful....stories may play for short spell....but ultimately, the business itself defines the future of real investors. It takes homework to determine the fundamental picture. Reading financials and evaluating pipelines, market potential, competition, results to date for biotechs is essential if you're investment horizon is beyond the next knee-jerk reaction of retailers. TARA is almost the perfect biotech, IMO. It doesn't just have science, but proven science. The bladder cancer results we just saw were stellar. On the CC this week, mgt was giddy and the doctor using the treatment in trials was also giddy. The need is substantial and TARA seems poised to change the landscape for bladder cancer treatment, the 6th most common cancer in the world. I could go on and on....JMO
0 · Reply
Drugtrade
Drugtrade Dec. 5 at 3:11 PM
$TARA near perfect financing execution.. more faith in management now. Cant always get those +500% pump on private placment news.. this isnt that type of investment (bearish tag because i want in sub 5 as if thats gona happen)
0 · Reply
pablo4
pablo4 Dec. 5 at 3:04 PM
$TARA retailers can be stupid....but thanks for selling me some shares below 5.10 today. JMO
0 · Reply